Clinical Analysts In51Patients With Parotid Gland Tumor

Salivary gland tumors is one of the most common facial tumor, accountsfor about3%-5%in the head and neck cancer, and80%of salivary glandtumors occur in the parotid gland approximately, including benign tumorsaccounting for about3/4[1]. Peking University School of Stomatology, Oral andMaxillofacial Surgery on4410cases of salivary gland tumors treated2803cases of parotid tumors, accounting for63.6%of the cases reported. A longtime, surgery is still the main treatment options for parotid gland of varioustypes of tumors. With the development of Surgical Oncology, parotid tumorsurgery has gone through the parotid gland partial resection of the"enucleation" to the specification of the parotid gland lobectomy. The past20years due to the parotid gland anatomy and the pathological nature of cognition,functional parotid surgery resulting, on the basis of clinical experience andacademic knowledge, which aims to cure cancer on the basis of as much aspossible to preserve its shape and function, as well as reduce the occurrence ofpostoperative complications, which also contributed to the standardization ofthe parotid gland tumor treatment programs, and improve its therapeutic levelscontinuously[2].Objective: By summarizing and analyzing diagnosis and clinical treatmentof51patients with parotid gland tumor,in order to improve patient cure rateand reduce postoperative complications, and improve patients’ quality of life.Methods: Retrospective survey of51patients in Department ofOtolaryngology Head and Neck Surgery of China-Japan Union Hospital fromMarch2010to September2011. By summarizing and analyzing the clinicaldata,pathological classification and surgery program,in order to observe theoccurrence of the postoperative scar, temporary facial paralysis, salivary fistula, Frey’s syndrome (Freys syndrome) and ear skin numbness,to invest thepostoperative satisfaction.Results:51patients with postoperative pathology report showed:25patients(49%) with pleomorphic adenoma,13patients(25%) with a Warthintumor,2patients(4%) with myoepithelioma,2patients(4%) based cell adenoma,2patients(4%) with lymphoid tube tumors,2patients(4%) with lymphepithelial cyst,2patients(4%) with mucoepidermoid carcinoma,1patients(2%)with adenoid cystic carcinoma,2in patients(4%) with acinar cell carcinoma.51cases were treated by surgery,9patients (18%) with subjective reports of Freysyndrome symptoms, began in6-12months after operation;7patients(14%)with temporary facial paralysis. after6months follow-up, the facial paralysisdisappeared;2patients(4%) with permanent facial paralysis, because ofmalignant tumor invasion and removal of the nerve caused; ear weeksnumbness of the other complications (21%), salivary fistula (6%), lower teethand lower lip numbness (2%), hematoma (2%), infection (2%). Thepostoperative recovery satisfactions of patients are different.Conclusions: Parotid tumors preferred surgery, which can be integrated tothe patient’s aesthetic requirements.Using the reansonable treatment on thebasis of radical tumor, to improve the cure rate of patients, and reducepostoperative complications.